ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,21
-0,79%
Dow Jones
40 211,72
0,53%
DAX
18 499,78
-0,54%
Brent Oil
83,175
-1,38%
Bitcoin
63 765,98
-1,67%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
12/01/202212h00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation for HMPL-523LSE:0J7GHutchison China Meditech Ltd
10/01/202208h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase I Study of HMPL-760LSE:0J7GHutchison China Meditech Ltd
31/12/202108h00UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
31/12/202107h59UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
20/12/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Included in FTSE Russell IndexesLSE:0J7GHutchison China Meditech Ltd
15/12/202110h44UK RegulatoryHutchmed (China) Limited Grant of Share Options and Awards under LTIPLSE:0J7GHutchison China Meditech Ltd
14/12/202108h00RNS Non-RegulatoryHutchmed (China) Limited HMPL-523 Clinical Data Presented at ASHLSE:0J7GHutchison China Meditech Ltd
10/12/202110h59RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Presents Data at ESMO Immuno-Oncology '21LSE:0J7GHutchison China Meditech Ltd
06/12/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Completes Planned Enrollment of FRESCO-2LSE:0J7GHutchison China Meditech Ltd
03/12/202108h00UK RegulatoryHutchmed (China) Limited Updated NRDL to include ELUNATE and SULANDALSE:0J7GHutchison China Meditech Ltd
24/11/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and AZ Initiate SACHI Phase 3 TrialLSE:0J7GHutchison China Meditech Ltd
08/11/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Present Clinical Data at ASHLSE:0J7GHutchison China Meditech Ltd
01/11/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and AZ Initiate SAMETA Global P3 TrialLSE:0J7GHutchison China Meditech Ltd
28/10/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase III Trial of HMPL-523LSE:0J7GHutchison China Meditech Ltd
20/10/202110h30UK RegulatoryHutchmed (China) Limited Grant of Awards under Long Term Incentive PlanLSE:0J7GHutchison China Meditech Ltd
29/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at CSCO 2021LSE:0J7GHutchison China Meditech Ltd
29/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited Closure of Non-Core OTC Joint Venture DivestmentLSE:0J7GHutchison China Meditech Ltd
21/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase III Trial SURTORI-01LSE:0J7GHutchison China Meditech Ltd
20/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited Japan Bridging Study For Surufatinib InitiatedLSE:0J7GHutchison China Meditech Ltd
13/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation for AmdizalisibLSE:0J7GHutchison China Meditech Ltd
08/09/202112h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and AZ Initiate Phase III Trial in ChinaLSE:0J7GHutchison China Meditech Ltd
07/09/202110h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Present Clinical Data at ESMOLSE:0J7GHutchison China Meditech Ltd
06/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Shares Included in Stock Connect ProgramsLSE:0J7GHutchison China Meditech Ltd
02/09/202113h45UK RegulatoryHutchmed (China) Limited Grant of Share Options, and Awards under LTIPLSE:0J7GHutchison China Meditech Ltd
26/08/202108h00RNS Non-RegulatoryHutchmed (China) Limited Phase Ib/II Trial of Fruquintinib & TislelizumabLSE:0J7GHutchison China Meditech Ltd
23/08/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Selected for Certain Hang Seng IndexesLSE:0J7GHutchison China Meditech Ltd
17/08/202110h30UK RegulatoryHutchmed (China) Limited ELECTRONIC COMMUNICATION OF CORPORATE INFORMATIONLSE:0J7GHutchison China Meditech Ltd
09/08/202108h00UK RegulatoryHutchmed (China) Limited HUTCHMED & Epizyme Announce TAZVERIK CollaborationLSE:0J7GHutchison China Meditech Ltd
28/07/202113h00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
28/07/202108h00RNS Non-RegulatoryHutchmed (China) Limited Phase II Trial of ORPATHYS InitiatedLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
DG
Vinci
USI
USTECH100
US Tech 100
NYSE
MCD
McDonalds
EU
RI
Pernod Ricard
NYSE
JPM
JP Morgan Chase
EU
PX4
SBF 120
EU
BEL20
Bel 20
EU
CS
Axa
NASDAQ
AAPL
Apple
FTSE
UKX
FTSE 100
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés